Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 7 | 2023 | 245 | 1.870 |
Why?
|
| Macrophages | 7 | 2023 | 557 | 1.750 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 91 | 0.900 |
Why?
|
| Malaria, Cerebral | 2 | 2019 | 4 | 0.880 |
Why?
|
| Malaria, Falciparum | 2 | 2019 | 12 | 0.870 |
Why?
|
| Interleukin-4 | 1 | 2021 | 127 | 0.760 |
Why?
|
| Antimalarials | 2 | 2019 | 20 | 0.760 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 18 | 0.750 |
Why?
|
| Plasmodium falciparum | 2 | 2019 | 47 | 0.750 |
Why?
|
| Monocytes | 2 | 2019 | 216 | 0.740 |
Why?
|
| Plasmodium berghei | 1 | 2019 | 2 | 0.730 |
Why?
|
| Alendronate | 1 | 2019 | 12 | 0.700 |
Why?
|
| Leukocytes | 1 | 2020 | 202 | 0.680 |
Why?
|
| Tamoxifen | 1 | 2019 | 168 | 0.670 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2020 | 54 | 0.640 |
Why?
|
| Osteoporosis | 1 | 2019 | 121 | 0.620 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 33 | 0.540 |
Why?
|
| Lipoproteins | 1 | 2015 | 135 | 0.520 |
Why?
|
| Obesity | 1 | 2020 | 964 | 0.460 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1376 | 0.440 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 827 | 0.410 |
Why?
|
| Animals | 13 | 2023 | 26590 | 0.310 |
Why?
|
| Mice | 9 | 2023 | 11356 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 3095 | 0.280 |
Why?
|
| Inflammation | 4 | 2023 | 923 | 0.260 |
Why?
|
| Hypercholesterolemia | 2 | 2023 | 161 | 0.240 |
Why?
|
| Macrophage Activation | 2 | 2020 | 48 | 0.230 |
Why?
|
| Aorta | 2 | 2020 | 281 | 0.200 |
Why?
|
| Neutrophils | 1 | 2022 | 307 | 0.190 |
Why?
|
| Cells, Cultured | 5 | 2020 | 2819 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2020 | 149 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 231 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1924 | 0.180 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 255 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 263 | 0.170 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2019 | 4 | 0.170 |
Why?
|
| Microspheres | 1 | 2019 | 101 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2023 | 429 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2019 | 165 | 0.160 |
Why?
|
| Immunophenotyping | 1 | 2019 | 211 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 316 | 0.160 |
Why?
|
| Disease Progression | 2 | 2019 | 1532 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 295 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 302 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2231 | 0.150 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2016 | 6 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1961 | 0.150 |
Why?
|
| Capillary Permeability | 1 | 2016 | 130 | 0.140 |
Why?
|
| Cell Movement | 1 | 2019 | 758 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1458 | 0.130 |
Why?
|
| beta Catenin | 1 | 2016 | 251 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2014 | 79 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 37 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 78 | 0.120 |
Why?
|
| Humans | 8 | 2022 | 86678 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 87 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 92 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 109 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 241 | 0.110 |
Why?
|
| Biomarkers | 1 | 2019 | 1718 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 381 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 428 | 0.100 |
Why?
|
| Protein Binding | 1 | 2015 | 1457 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2014 | 673 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 683 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1579 | 0.090 |
Why?
|
| Receptors, LDL | 2 | 2020 | 53 | 0.090 |
Why?
|
| CX3C Chemokine Receptor 1 | 2 | 2019 | 5 | 0.080 |
Why?
|
| Female | 4 | 2021 | 44550 | 0.080 |
Why?
|
| Male | 4 | 2023 | 40988 | 0.070 |
Why?
|
| Septins | 1 | 2023 | 6 | 0.060 |
Why?
|
| Staphylococcus epidermidis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 2380 | 0.050 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 54 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 144 | 0.050 |
Why?
|
| Bacteremia | 1 | 2022 | 99 | 0.050 |
Why?
|
| Cholesterol | 1 | 2023 | 356 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2022 | 204 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2023 | 3243 | 0.050 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2020 | 7 | 0.050 |
Why?
|
| Apolipoprotein B-100 | 1 | 2020 | 12 | 0.050 |
Why?
|
| Neuropilin-1 | 1 | 2020 | 14 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 104 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2020 | 20 | 0.050 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 36 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2020 | 69 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 155 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 114 | 0.040 |
Why?
|
| Diet, Western | 1 | 2019 | 37 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 778 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 350 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 339 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 286 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 17 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2017 | 31 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2017 | 28 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 35 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 134 | 0.040 |
Why?
|
| Dependovirus | 1 | 2017 | 33 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 95 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 75 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2016 | 68 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 68 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2016 | 50 | 0.040 |
Why?
|
| Microvessels | 1 | 2016 | 70 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 864 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 273 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 217 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 439 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 420 | 0.030 |
Why?
|
| Ploidies | 1 | 2014 | 40 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1565 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 435 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 258 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 256 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 286 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 407 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 1047 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 580 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 2216 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 7998 | 0.020 |
Why?
|